The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
The MORDOR study, a cluster randomized clinical trial, showed that single-dose azithromycin (20 mg/kg) administered biannually for 2 years to preschool children reduced mortality; a study was conducted to dete...
Source: Malaria Journal - Category: Infectious Diseases Authors: Evan M. Bloch, Beatriz Munoz, Zakayo Mrango, Jerusha Weaver, Leonard E. G. Mboera, Tom M. Lietman, David J. Sullivan Jr. and Sheila K. West Tags: Research Source Type: research
More News: Azithromycin | Children | Clinical Trials | Infectious Diseases | Malaria | Study | Zithromax